Skip to main content

This job has expired

National Market Access Lead

Employer
UCB S.A
Location
Slough, Berkshire (GB)
Salary
Competitive
Start date
7 Nov 2019
Closing date
7 Dec 2019

View more

Job Details

National Market Access Lead
UCB – Inspired by patients. Driven by science
Help us transform patients’ lives

About UCB

At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talent makes the most of who they are, unlocking innovation and setting new standards for patients.

Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

To strengthen our National Market Access Group, we are looking to fill the position of: National Market Access Lead. 

What We Offer
An opportunity to:

  • Be supported to flourish in this high performing culture, where patients are at the heart of what drives our decision making.
  • Be empowered and developed through exposure to an integrated business approach, you will have the opportunity to work collaboratively with Global, European and affiliate experts.
  • Have a diverse portfolio and be driven by world leading science, patient access to our innovative medicines is a priority at UCB.
  • Drive the development of innovative and implementable access tools, solutions and frameworks

About the Role
You will be responsible for:

  • Leading, and developing clear and commercially driven Market Access strategies and HTA submission by utilising stakeholder insights and on trend market knowledge of health economics.
  • Being the face of UCB for all external HTA communications including representation at committee meetings.
  • Developing and executing high quality Pricing & Reimbursement strategies and HTA submissions for the UK & Ireland.
  • Leading key consultations, shaping and inputting into National clinical guideline reviews, therapeutic consultations, quality standards and competitor consultations.
  • Supporting UCB's Market Access capability and being the internal expert on the reimbursement environment and share knowledge; being the expert on HTA policies and methodologies.
  • Leading on national HTA submissions; optimising national clinical guidelines reviews, therapeutic consultations, quality standards and competitor consultations regional business case submissions.
  • Developing an external network with leaders in the field of Health Economics and P&R, driving customer insight on current and future clinical practice to inform national HTA submissions.
  • Collaborating to ensure robust project plans are developed with clear expectation of deliverables and responsibilities.
  • Building productive working partnerships with Global and European Market Access pricing teams to develop pricing strategies and commercial schemes.

About You
You should have:

  • MSc or PhD in Health Economics (or equivalent).
  • Substantial Health Economics experience within the Pharmaceutical Industry and previous market or market access experience.
  • Demonstrable ability to plan at a business unit level of complexity and a marketing programmes
  • Expert knowledge of NHS structures, processes and policies, decision making networks and understanding of therapy areas.
  • Strong knowledge of the UK political and healthcare policy environment and experience of Health Economic Submissions.
  • Experience having written HTA submissions, applying to NICE and being successful. 

UCB – The Facts

With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work:

  • Promising pipeline that includes several novel molecules and no major patent expiration in the next decade;
  • About 25% of 2016 revenue reinvested into Research & Development
  • 2016 Key Financials: €4.2 billion global revenue Specialties: Neurology, Immunology

Company

A global biopharma company, focusing on neurology and immunology.

Our business is strong. Total revenue grew to €4.9 billion in 2019. We are more than 7,600 people in all four corners of the globe, inspired by patients and driven by science.

Our vision

UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science.

UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions – so that they and their carers can get on with their lives.

Our strategy

We recognise that radical changes are taking place in the eco-system of care and that we need to evolve accordingly to deliver on our vision. The key element of our evolution is to focus on the delivery of increased patient value.

There is no such thing as an “average patient”. We want to use all the tools, channels and scientific advances at our disposal to develop a better understanding of the various expressions of a disease and embed the real needs of specific patient populations in our science and innovation process.

That is why we support patient groups who provide valuable services to patient communities and understand what matters to people living with severe diseases.

We believe in partnership. Our scientists collaborate with leading researchers from academia and industry to advance science and deliver the solutions patients need. Our open approach to innovation equips us to meet today’s biggest healthcare challenges.

Company info
Website
Telephone
+32 2 559 92 64
Location
Allée de la Recherche,
60
1070
Brussels
BE

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert